NCT01076543 · MORE INFO

Limitations, agreements, and source contact

Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma · Source last updated 2019-10-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee: false
restriction Type: LTE60
restrictive Agreement: true

point Of Contact

email: smsmith@medicine.bsd.uchicago.edu
organization: University of Chicago
phone: 773-834-2895
title: Dr. Sonali Smith, Professor of Medicine

Complete source fields

certain Agreement

pi Sponsor Employee: false
restriction Type: LTE60
restrictive Agreement: true

point Of Contact

email: smsmith@medicine.bsd.uchicago.edu
organization: University of Chicago
phone: 773-834-2895
title: Dr. Sonali Smith, Professor of Medicine

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice